Clinical Trial Update: The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of tofacitinib with iguratimod in rheumatoid arthritis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED